Theravance Biopharma Inc (FRA:0TB)
€ 14.6 -0.10 (-0.68%) Market Cap: 767.00 Mil Enterprise Value: 455.95 Mil PE Ratio: 7.66 PB Ratio: 2.99 GF Score: 72/100

Zymeworks Inc to Acquire Theravance Biopharma Inc Transcript

Jun 29, 2026 / 12:30 PM GMT
Release Date Price: €15.3 (+1.32%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

TBPH.OQ - Theravance Biopharma Inc
Zymeworks Inc to Acquire Theravance Biopharma Inc
Jun 29, 2026 / 12:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Thank you for standing by. This is the conference operator. Welcome to ZymeWorks' conference call and webcast to discuss the acquisition of TheraVance Biopharma. As a reminder, all participants are in a listen-only mode, and the conference is being recorded. After the presentation, there will be an opportunity to ask questions. I would now like to turn the conference over to Shrenelle Inamdar, Vice President of Investor.

For now, please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, operator. Good afternoon, everyone, and thank you for
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot